Business
The newly public company, now trading on Nasdaq under the ticker symbol "AKLI," will use the proceeds from the transaction to launch EndeavorRx, its video game-like digital therapeutic for children with ADHD.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
The startup connects new mental health providers with supervisors to complete their licensure requirements. The new funding brings its total raise to $16.3 million.
It is now preparing for a Series A fundraising round in the next six months.
Medication management-focused Arine raised $29 million, Epic-based virtual care platform KeyCare scooped up $24 million, and care coordination software company CareHarmony raised $15 million.
The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.
A memo sent to employees from CEO David Ko said the company is "not immune to the impacts of the current economic environment."